Study to Evaluate Satisfaction After Treatment With Restylane

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-16

Study Completion Date

2021-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation

NCT03160716

Cheek Augmentation Midface Contour Deficiencies

COMPLETED NA

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

NCT05777759

Chin Augmentation Chin Retrusion

COMPLETED NA

A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

NCT06428214

Chin Augmentation

COMPLETED NA

Midfacial Product Selection

NCT03381040

Facial Volume Loss

COMPLETED PHASE4

A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers

NCT03869450

Volume Deficiency of the Midface

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cheek Augmentation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Restylane Volyme

Hyaluronic Acid

Group Type EXPERIMENTAL

Restylane Volyme

Intervention Type DEVICE

Hyaluronic Acid: Injectable gel for contouring effect (of cheek volumization).

Restylane Lyft Lidocaine

Hyaluronic Acid

Group Type EXPERIMENTAL

Restylane Lyft Lidocaine

Intervention Type DEVICE

Hyaluronic Acid: Injectable gel for projection effect (of cheek augmentation).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Restylane Volyme

Hyaluronic Acid: Injectable gel for contouring effect (of cheek volumization).

Intervention Type DEVICE

Restylane Lyft Lidocaine

Hyaluronic Acid: Injectable gel for projection effect (of cheek augmentation).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed and dated informed consent to participate in the study
* Adult women who intend to undergo cheek augmentation

Exclusion Criteria

* Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics
* Subjects with a previous implant other than HA in or near the intended treatment site
* Participation in any other clinical study within three (3) months before treatment

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes